In summary, results obtained from this study demonstrate that RA-3 improved glucose tolerance and pancreatic beta cell ultrastructure by inhibiting inflammation through the reduction of IL-6 levels and enhanced antioxidant status of the type 2 diabetic rats. Here, IL6 is linked to type 2 diabetes mellitus.